VNA integrates HRS solution to reduce readmissions
MANCHESTER, N.H. – The Visiting Nurse Association of Manchester and Southern New Hampshire has added a patient monitoring solution from Health Recovery Solutions to reduce readmissions for high-risk patients and improve quality of care. “The HRS solution is helping us add another level of care and support for our patients and empowering our staff,” said Carla Braveman, vice president, Home and Community Services, VNA of Manchester and Southern NH, in a statement. The HRS platform combines patient engagement software with biometric monitoring and mobile apps. All data captured through the devices is automatically transmitted back to the clinical team in seconds, allowing real-time interventions. The solution also triggers alerts for patients at high risk of medical emergencies. The agency is providing their patients with the HRS software on tablets and Bluetooth biometric devices.
Multi-use life support device clears FDA
BOTHELL, Wash. – VOCSN, a portable life support device for patients with neuromuscular disease, impaired lung function, spinal cord injury and pediatric development complications, has received clearance from the U.S. Food and Drug Administration. “Our team didn’t want to create just another ventilator—we spent the past five years focused on building a truly integrated solution,” said Doug DeVries, founder and CEO of Ventec, the maker of VOCSN. The device works across the continuum of care, from hospital to home, and combines ventilation, oxygen, cough, suction and nebulization. It is 70% lighter and smaller than existing machines, features a nine-hour on-board battery and is controlled through an intuitive touchscreen interface. Caregivers can seamlessly switch between therapies by touching a button.
Digital Pharmacist acquires PocketRx
AUSTIN – Digital health company Digital Pharmacist has acquired the mobile app PocketRx, allowing the company to accelerate its product development schedule. Praesus LLC developed the app and will provide software development and support for Digital Pharmacist, which powers digital and communication products for more than 6,000 pharmacies nationwide. “By combining the very best features of the PocketRx app with our existing content-rich product suite, we are able to offer patients the easiest, most integrated tools to manage their medications,” said Chris Loughlin, CEO of Digital Pharmacist.
Spectrum Generations partners with Senscio Systems for chronic care management
BANGOR, Me. – Spectrum Generations will partner with AI technology developer Senscio Systems to provide personalized health care services to mid-coast Maine residents with complex chronic conditions. “Spectrum’s caregiving expertise combined with Senscio’s technology provides the perfect combination of technology and touch required for complex chronic care,” said Dr. Piali De, CEO of Senscio Systems, in a statement. De said Senscio’s artificially intelligent digital therapeutics platform, Ibis Care, proactively recognizes a person’s loss of control over their health and initiates the process to regain it. “As we look to the future of an increasing population of older adults, Senscio’s Ibis Care offers the most comprehensive, efficient and scalable solution for chronic care management,” said Gerard Queally, CEO of Spectrum.
Facial recognition tool improves adherence, study finds
NEW YORK – AiCure’s artificial intelligence platform led to a 50% improvement in medication adherence for stroke patients, a recent study has found.
“In the absence of routine laboratory monitoring, artificial intelligence has the potential to automate a critical component of care—adherence monitoring—and provide continuity of care between visits to ensure patients persist with their therapy and get full therapeutic benefit,” said Dr. Daniel Labovitz, lead author of a paper on the study and director of the Stern Stroke Center at Montefiore Medical Center, in a statement.
The 12-week study included ischemic stroke survivors randomly assigned to the AI platform for daily monitoring or treatment as usual groups. To measure treatment adherence, researchers tested the concentration of medication in blood samples. Blood tests showed that 100% of patients in the intervention arm took medication regularly, compared to only half in the control arm.
The AiCure platform uses software algorithms on smartphones to automatically confirm patient identity, the medication and ingestion. In addition, patients receive automated reminders and precise dosing instructions, and healthcare workers can review real-time data. Early detection of non-adherence allowed for immediate follow up and ensured patients stayed on track in the intervention group.
The study demonstrated that patients with little prior experience using a smartphone were able to easily learn how to use the technology and use it consistently, said Labovitz.
Healthbox launches digital health sourcing tool
CHICAGO – Healthcare innovation consulting firm Healthbox has launched a platform to help health care organizations evaluate digital health tools.
Horizon Scan is intended to serve as a sourcing tool to successfully find and evaluate innovative digital health solutions.
“Horizon Scan will help teams successfully navigate the digital health landscape with added confidence and speed,” said Neil Patel, president of Healthbox, in a statement.
Horizon Scan provides health care organizations with company profiles of thousands of digital health startups, based on information that Healthbox has curated and evaluated. Through the platform, health care organizations can find new digital solutions for accelerator programs, investment decisions and sourcing vendor solutions.
Horizon Scan also features industry reports and a community network of other health care organizations.
Parkinson’s assessments possible through eVisits, study finds
NEW YORK – Results of a recent study have found that motor and non-motor assessments through virtual research visits are feasible in individuals with Parkinson’s Disease.
The telehealth study was conducted through the University of Rochester Medical Center in collaboration with real-time virtual care solutions provider AMC Health.
“We are very encouraged by these interim results that demonstrate the value of offering eVisits to clinical trial participants to reduce their burden, and leads to the likelihood that more patients will participate in clinical trials in the future,” said Michael O’Brien, president of the Clinical Trials Division of AMC Health, in a statement.
The study is a sub-study of a larger National Institutes of Health-funded Phase 3 trial, which assessed the feasibility, reliability and value of deploying virtual eVisits in a Parkinson’s Disease study population compared to traditional in-person visits.
The virtual visit deploys a smartphone, which provides a secure video connection between the study subject at home and the clinical study team. During the eVisit session, blood pressure and weight measurements are collected via Bluetooth sensor devices, and a series of motor and non-motor assessments are conducted by the study team and entered through on-screen clinical assessment workflows.
The study also included patient-reported assessments to determine ease of use, patient satisfaction and the likelihood that patients believe virtual visits would benefit future trials.
“We hope this study will lay the foundation for bringing clinical trials to participants in the future,” said Dr. Ray Dorsey, professor of neurology and director of the Center for Human Experimental Therapeutics at the University of Rochester Medical Center, in a statement. “Clinical trials should reduce, not increase, the burden on those that volunteer to participate in them.”